β-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells

Molecular Medicine

Volumn 5, Issue 11, 1999, Pages 711-720

  Huang, L ^a   Pardee, A B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA LAPACHONE; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; DNA CONTENT; DNA DAMAGE; ENZYME INHIBITION; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0033276625     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402095     Document Type: Article

References (42)

1. Generation of superoxide anions and hydrogen peroxide from beta-lapachone in bacteria
2. Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone
3. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi
4. Beta-lapachone an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-alpha. Inhibitory effect, thiol dependence and specificity
5. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication
6. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response
7. Induction of apoptosis by beta-lapachone in human prostate cancer cells
8. Topoisomerase-I inhibitors for human malignant glioma differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone
9. Beta-lapachone induced cell death in human hepatoma cells (HepA2) cells
10. Induction of apoptosis in MCF-7-WS8 breast cancer cells by beta-lapachone
11. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells
12. Potent inhibition of tumor survival in vivo by β-lapachone plus taxol; combining drugs imposing different artificial checkpoints
13. Effect of beta-lapachone on hydrogen peroxide production in Trypanosoma cruzi
14. Beta-lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin
15. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
16. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones
17. DNA topoisomerases
18. DNA topoisomerase poisons as antitumor drugs
19. Diversity of DNA topoisomerases I and inhibitors
20. Beta-lapachone greatly enhances MMS lethality to human fibroblasts
21. Potentiation of halogenated pyrimidine adiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione, a novel DNA repair inhibitor
22. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I
23. The production of chromosomal alterations by beta-lapachone, an activator of topoisomerase I
24. p53 status and the efficacy of cancer therapy in vivo
25. Cancer therapy and p53
26. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
27. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence
28. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers
29. Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells
30. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
31. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
32. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines
33. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts
34. p53 in signaling checkpoint arrest or apoptosis
35. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo
36. Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis
37. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
38. Bcl-2 and the regulation of programmed cell death
39. Regulators of cell death
40. DNA damage and cytotoxicity induced by beta-lapachone: Relation to poly (ADP-ribose) polymerase inhibition
41. Gain of function mutations in p53
42. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations